Plasma Lipid Profiling Contributes to Untangle the Complexity of Moyamoya Arteriopathy
Moyamoya arteriopathy (MA) is a rare cerebrovascular disorder characterized by ischemic/hemorrhagic strokes. The pathophysiology is unknown. A deregulation of vasculogenic/angiogenic/inflammatory pathways has been hypothesized as a possible pathophysiological mechanism. Since lipids are implicated in modulating neo-vascularization/angiogenesis and inflammation, their deregulation is potentially involved in MA. Our aim is to evaluate angiogenic/vasculogenic/inflammatory proteins and lipid profile in plasma of MA patients and control subjects (healthy donors HD or subjects with atherosclerotic cerebrovascular disease ACVD). Angiogenic and inflammatory protein levels were measured by ELISA and a complete lipidomic analysis was performed on plasma by mass spectrometry. ELISA showed a significant decrease for MMP-9 released in plasma of MA. The untargeted lipidomic analysis showed a cumulative depletion of lipid asset in plasma of MA as compared to HD. Specifically, a decrease in membrane complex glycosphingolipids peripherally circulating in MA plasma with respect to HD was observed, likely suggestive of cerebral cellular recruitment. The quantitative targeted approach demonstrated an increase in free sphingoid bases, likely associated with a deregulated angiogenesis. Our findings indicate that lipid signature could play a central role in MA and that a detailed biomarker profile may contribute to untangle the complex, and still obscure, pathogenesis of MA..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
International Journal of Molecular Sciences - 22(2021), 24, p 13410 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Michele Dei Cas [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Angiogenesis |
|---|
| doi: |
10.3390/ijms222413410 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ014179334 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ014179334 | ||
| 003 | DE-627 | ||
| 005 | 20240414224811.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijms222413410 |2 doi | |
| 035 | |a (DE-627)DOAJ014179334 | ||
| 035 | |a (DE-599)DOAJf4133939fdc541eeb79ae7bfa3bf4715 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a QH301-705.5 | |
| 050 | 0 | |a QD1-999 | |
| 100 | 0 | |a Michele Dei Cas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Plasma Lipid Profiling Contributes to Untangle the Complexity of Moyamoya Arteriopathy |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Moyamoya arteriopathy (MA) is a rare cerebrovascular disorder characterized by ischemic/hemorrhagic strokes. The pathophysiology is unknown. A deregulation of vasculogenic/angiogenic/inflammatory pathways has been hypothesized as a possible pathophysiological mechanism. Since lipids are implicated in modulating neo-vascularization/angiogenesis and inflammation, their deregulation is potentially involved in MA. Our aim is to evaluate angiogenic/vasculogenic/inflammatory proteins and lipid profile in plasma of MA patients and control subjects (healthy donors HD or subjects with atherosclerotic cerebrovascular disease ACVD). Angiogenic and inflammatory protein levels were measured by ELISA and a complete lipidomic analysis was performed on plasma by mass spectrometry. ELISA showed a significant decrease for MMP-9 released in plasma of MA. The untargeted lipidomic analysis showed a cumulative depletion of lipid asset in plasma of MA as compared to HD. Specifically, a decrease in membrane complex glycosphingolipids peripherally circulating in MA plasma with respect to HD was observed, likely suggestive of cerebral cellular recruitment. The quantitative targeted approach demonstrated an increase in free sphingoid bases, likely associated with a deregulated angiogenesis. Our findings indicate that lipid signature could play a central role in MA and that a detailed biomarker profile may contribute to untangle the complex, and still obscure, pathogenesis of MA. | ||
| 650 | 4 | |a moyamoya arteriopathy | |
| 650 | 4 | |a lipidomics | |
| 650 | 4 | |a angiogenesis | |
| 650 | 4 | |a vasculogenesis | |
| 650 | 4 | |a inflammation | |
| 650 | 4 | |a RNF213 | |
| 653 | 0 | |a Biology (General) | |
| 653 | 0 | |a Chemistry | |
| 700 | 0 | |a Tatiana Carrozzini |e verfasserin |4 aut | |
| 700 | 0 | |a Giuliana Pollaci |e verfasserin |4 aut | |
| 700 | 0 | |a Antonella Potenza |e verfasserin |4 aut | |
| 700 | 0 | |a Sara Nava |e verfasserin |4 aut | |
| 700 | 0 | |a Isabella Canavero |e verfasserin |4 aut | |
| 700 | 0 | |a Francesca Tinelli |e verfasserin |4 aut | |
| 700 | 0 | |a Gemma Gorla |e verfasserin |4 aut | |
| 700 | 0 | |a Ignazio G. Vetrano |e verfasserin |4 aut | |
| 700 | 0 | |a Francesco Acerbi |e verfasserin |4 aut | |
| 700 | 0 | |a Paolo Ferroli |e verfasserin |4 aut | |
| 700 | 0 | |a Elisa F. Ciceri |e verfasserin |4 aut | |
| 700 | 0 | |a Silvia Esposito |e verfasserin |4 aut | |
| 700 | 0 | |a Veronica Saletti |e verfasserin |4 aut | |
| 700 | 0 | |a Emilio Ciusani |e verfasserin |4 aut | |
| 700 | 0 | |a Aida Zulueta |e verfasserin |4 aut | |
| 700 | 0 | |a Rita Paroni |e verfasserin |4 aut | |
| 700 | 0 | |a Eugenio A. Parati |e verfasserin |4 aut | |
| 700 | 0 | |a Riccardo Ghidoni |e verfasserin |4 aut | |
| 700 | 0 | |a Anna Bersano |e verfasserin |4 aut | |
| 700 | 0 | |a Laura Gatti |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t International Journal of Molecular Sciences |d MDPI AG, 2003 |g 22(2021), 24, p 13410 |w (DE-627)DOAJ00014584X |x 14220067 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2021 |g number:24, p 13410 |
| 856 | 4 | 0 | |u https://doi.org/10.3390/ijms222413410 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/f4133939fdc541eeb79ae7bfa3bf4715 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.mdpi.com/1422-0067/22/24/13410 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1661-6596 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1422-0067 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2021 |e 24, p 13410 | ||